| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-07 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.12 | 6e-06 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.13 | 9e-06 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.12 | 4e-05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.11 | 5e-05 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.11 | 5e-05 |